<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2013, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 06 Jun 2011 07:45:36 -0500</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Cell Therapeutics (CTICD) Announces Positive Results in Phase II OPAL Study of Tosedostat in Elderly Patients</title>
   <link>http://www.streetinsider.com/Analyst+Comments/Cell+Therapeutics+%28CTICD%29+Announces+Positive+Results+in+Phase+II+OPAL+Study+of+Tosedostat+in+Elderly+Patients/6561322.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Analyst+Comments/Cell+Therapeutics+%28CTICD%29+Announces+Positive+Results+in+Phase+II+OPAL+Study+of+Tosedostat+in+Elderly+Patients/6561322.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/Cell+Therapeutics+%28CTICD%29+Announces+Positive+Results+in+Phase+II+OPAL+Study+of+Tosedostat+in+Elderly+Patients/6561322.html</guid>
   <pubDate>Mon, 06 Jun 2011 07:45:36 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTICD</category>
   	  </item>
  <item>
   <title>Cell Therapeutics (CTICD) Regains Nasdaq Listing Compliance</title>
   <link>http://www.streetinsider.com/Corporate+News/Cell+Therapeutics+%28CTICD%29+Regains+Nasdaq+Listing+Compliance/6550504.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Cell+Therapeutics+%28CTICD%29+Regains+Nasdaq+Listing+Compliance/6550504.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Cell+Therapeutics+%28CTICD%29+Regains+Nasdaq+Listing+Compliance/6550504.html</guid>
   <pubDate>Wed, 01 Jun 2011 06:46:11 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTICD</category>
   	  </item>
  <item>
   <title>Cell Therapeutics (CTICD) IDs Potential Immunotherapy Drug Candidate Acquisition</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/Cell+Therapeutics+%28CTICD%29+IDs+Potential+Immunotherapy+Drug+Candidate+Acquisition/6539830.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Mergers+and+Acquisitions/Cell+Therapeutics+%28CTICD%29+IDs+Potential+Immunotherapy+Drug+Candidate+Acquisition/6539830.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/Cell+Therapeutics+%28CTICD%29+IDs+Potential+Immunotherapy+Drug+Candidate+Acquisition/6539830.html</guid>
   <pubDate>Thu, 26 May 2011 06:49:56 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTICD</category>
   	  </item>
  <item>
   <title>Cell Therapeutics (CTICD) IDs Potential Immunotherapy Drug Candidate Acquisition</title>
   <link>http://www.streetinsider.com/FDA/Cell+Therapeutics+%28CTICD%29+IDs+Potential+Immunotherapy+Drug+Candidate+Acquisition/6539830.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/FDA/Cell+Therapeutics+%28CTICD%29+IDs+Potential+Immunotherapy+Drug+Candidate+Acquisition/6539830.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/Cell+Therapeutics+%28CTICD%29+IDs+Potential+Immunotherapy+Drug+Candidate+Acquisition/6539830.html</guid>
   <pubDate>Thu, 26 May 2011 06:49:56 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTICD</category>
   	  </item>
  <item>
   <title>Cell Therapeutics (CTICD) IDs Potential Immunotherapy Drug Candidate Acquisition</title>
   <link>http://www.streetinsider.com/Corporate+News/Cell+Therapeutics+%28CTICD%29+IDs+Potential+Immunotherapy+Drug+Candidate+Acquisition/6539830.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Cell+Therapeutics+%28CTICD%29+IDs+Potential+Immunotherapy+Drug+Candidate+Acquisition/6539830.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Cell+Therapeutics+%28CTICD%29+IDs+Potential+Immunotherapy+Drug+Candidate+Acquisition/6539830.html</guid>
   <pubDate>Thu, 26 May 2011 06:49:56 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTICD</category>
   	  </item>
  <item>
   <title>Cell Therapeutics (CTIC) to Meet with FDA Over Pixantrone NDA Submission</title>
   <link>http://www.streetinsider.com/Corporate+News/Cell+Therapeutics+%28CTIC%29+to+Meet+with+FDA+Over+Pixantrone+NDA+Submission/6524805.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Cell+Therapeutics+%28CTIC%29+to+Meet+with+FDA+Over+Pixantrone+NDA+Submission/6524805.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Cell+Therapeutics+%28CTIC%29+to+Meet+with+FDA+Over+Pixantrone+NDA+Submission/6524805.html</guid>
   <pubDate>Fri, 20 May 2011 06:54:58 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTIC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTICD</category>
   	  </item>
  <item>
   <title>Cell Therapeutics (CTIC) to Meet with FDA Over Pixantrone NDA Submission</title>
   <link>http://www.streetinsider.com/FDA/Cell+Therapeutics+%28CTIC%29+to+Meet+with+FDA+Over+Pixantrone+NDA+Submission/6524805.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/FDA/Cell+Therapeutics+%28CTIC%29+to+Meet+with+FDA+Over+Pixantrone+NDA+Submission/6524805.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/Cell+Therapeutics+%28CTIC%29+to+Meet+with+FDA+Over+Pixantrone+NDA+Submission/6524805.html</guid>
   <pubDate>Fri, 20 May 2011 06:54:58 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTIC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTICD</category>
   	  </item>
  <item>
   <title>Cell Therapeutics (CTIC) to Meet with FDA Over Pixantrone NDA Submission</title>
   <link>http://www.streetinsider.com/Corporate+News/Cell+Therapeutics+%28CTIC%29+to+Meet+with+FDA+Over+Pixantrone+NDA+Submission/6524805.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Cell+Therapeutics+%28CTIC%29+to+Meet+with+FDA+Over+Pixantrone+NDA+Submission/6524805.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Cell+Therapeutics+%28CTIC%29+to+Meet+with+FDA+Over+Pixantrone+NDA+Submission/6524805.html</guid>
   <pubDate>Fri, 20 May 2011 06:54:58 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTIC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTICD</category>
   	  </item>
  <item>
   <title>Cell Therapeutics (CTIC) to Meet with FDA Over Pixantrone NDA Submission</title>
   <link>http://www.streetinsider.com/FDA/Cell+Therapeutics+%28CTIC%29+to+Meet+with+FDA+Over+Pixantrone+NDA+Submission/6524805.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/FDA/Cell+Therapeutics+%28CTIC%29+to+Meet+with+FDA+Over+Pixantrone+NDA+Submission/6524805.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/Cell+Therapeutics+%28CTIC%29+to+Meet+with+FDA+Over+Pixantrone+NDA+Submission/6524805.html</guid>
   <pubDate>Fri, 20 May 2011 06:54:58 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTIC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTICD</category>
   	  </item>
 </channel>
</rss>
